Venin-sourced demulcent CTXn, and purification method and applications thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 广州医学院
- Publication Date
- 2010-06-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a cytotoxin CTXn derived from snake venom for analgesia, a purification method and application thereof. A cytotoxin derived from the poison of Zhoushan cobra (Naja atra Cantor) is mainly used, which is suitable for analgesia, especially involving the new pharmaceutical application of the cytotoxin for treating acute and chronic pain. It belongs to the technical field of biopharmaceuticals. Background technique
[0002] Since the 1970s, NT has conducted in-depth research on the basic research of analgesia, and its analgesic mechanism may be related to various systems such as cholinergic and endogenous opioid peptides. Compared with the traditional analgesic drug morphine, the analgesic effect of NT has the characteristics of less dosage, longer analgesic time and no addiction, etc. It is effective for intractable pain, neuropathic pain and malignant tumor pain. In view of the high neurotoxicity and lethal activity of NT, it is...